ADMS
$3.90
Adamas Pharma
($.14)
(3.47%)
ADMS
Earnings Whisper ®
N/A
3rd Quarter September 2019
Consensus:  ($0.89)
Revenue:  $14.36 Mil
Thursday
Nov 7
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Thursday, August 8, 2019

What do you expect when ADMS reports earnings?
Beat
Meet
Miss

Where is ADMS's stock price going from here?
Up
Flat
Down
Stock chart of ADMS
Analysts
Summary of analysts' recommendations for ADMS
Score
Grade
Pivots
Resistance
$4.33
$4.21
$4.12

$4.00

Support
$3.91
$3.79
$3.70
Tweet
Growth
Peers
Regeneron PharmaceuticalsCelgeneInterCeptVertex PharmaceuticalsBioMarin PharmaceuticalEndo International plcJohnson & JohnsonMylanZoetisPerrigo